The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Medicare Advantage Plans Rethink Post-Discharge Care Transitions

Leading Medicare Advantage plans are putting new emphasis on care transitions, the fragile stretch after a patient leaves the hospital, according to Healthcare Dive. The period between discharge and recovery at home is where members often fall through the cracks: missed follow-up appointments, confusion over new medications, and gaps between providers that can send patients back to the hospital.

The stakes are tied directly to Star Ratings, the quality scores that drive bonus payments and enrollment. Readmissions and poorly managed transitions drag those scores down, so plans are treating the post-discharge window as a core quality lever rather than an afterthought. In practice, that means investing in timely outreach, medication reconciliation, and tighter coordination across hospitals, primary care, and home-based support.

The broader shift reframes care management as something that must extend well past the hospital walls. For payers, the message is that Star Ratings and member outcomes increasingly hinge on execution in the days and weeks after discharge, not just the inpatient stay itself.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.